Aerovate Therapeutics, Inc. hired Marco Verwijs as SVP, CMC and Susan Fischer as SVP, Development Operations. Mr. Verwijs has over 15 years of product development and manufacturing experience. He has worked on multiple commercial products, leading them from clinical product development to New Drug Application filing and commercial launch.

Ms. Fischer has over 20 years of clinical operations experience in both academic and pharmaceutical industry settings. She previously led clinical operation teams at Syndax Pharmaceuticals Inc., Acetylon Pharmaceuticals, Inc. and EMD Serono, Inc. that included global clinical trial sites.